Gossamer Bio, Inc.
GOSS
$0.16
-$0.01-3.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -27.37% | -43.02% | -56.55% | -177.74% | 12.62% |
| Total Depreciation and Amortization | -32.16% | -78.88% | -79.96% | -78.53% | -65.31% |
| Total Amortization of Deferred Charges | 5.81% | 5.46% | 5.98% | -23.68% | -17.75% |
| Total Other Non-Cash Items | 2,254.20% | 1.34% | 474.68% | -68.03% | -108.51% |
| Change in Net Operating Assets | 153.18% | 39.40% | 174.77% | -115.50% | 76.88% |
| Cash from Operations | 2.52% | -36.17% | -12.91% | -140.45% | 24.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 88.36% | 37.47% | 163.59% | 174.74% | -64.19% |
| Cash from Investing | 88.59% | 37.47% | 163.59% | 174.65% | -64.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.59% | -- | 566.19% | -- | 44.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.59% | -- | 566.19% | 101.02% | 119.73% |
| Foreign Exchange rate Adjustments | -196.19% | 101.60% | -202.15% | 1,712.50% | 269.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 119.33% | 63.54% | 70.25% | -105.65% | -352.49% |